Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1675
Gene Symbol: CFD
CFD
0.310 GeneticVariation group BEFREE Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. 16527897 2006
Entrez Id: 1675
Gene Symbol: CFD
CFD
0.310 Biomarker group CTD_human Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. 16527897 2006
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 Biomarker group BEFREE Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. 20619376 2010
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 GeneticVariation group BEFREE The CFH-CFHR3-CFHR1 aHUS-risk haplotype seems to be the same as was previously associated with protection against meningococcal infections, suggesting that the genetic variability in this region is limited to a few extended haplotypes, each with opposite effects in various human diseases. 26163426 2015
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 GeneticVariation group BEFREE Genetic variations in the gene cluster encoding IL-1 and in key genes including TNF, SP-A2 and CFH have been associated with susceptibility to meningococcal disease. 23409824 2013
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 GeneticVariation group BEFREE The role of properdin in regulating complement in health and disease has not received as much appraisal as the many negative AP regulators, such as factor H. Historically, properdin deficiency has been strongly associated with an increased risk for meningococcal disease. 30141176 2019
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 Biomarker group BEFREE Our study confirms the association of CFH with susceptibility to MD and strengthens the importance of this link in understanding pathogenesis of the disease. 27805046 2016
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 Biomarker group BEFREE The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and rLP2086 that target the factor H binding protein (fHbp), an immunogenic surface component of Neisseria meningitidis present as one of three variants. 25247300 2014
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 Biomarker group BEFREE Our results support the conclusion that CFH is a critical determinant in acquiring meningococcal disease. 26135246 2015
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 GeneticVariation group BEFREE These data may explain the association between genetic variation in both CFH and CFHR3 and susceptibility to meningococcal disease. 25534642 2014
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 GeneticVariation group BEFREE Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 Biomarker group CTD_human Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.400 GeneticVariation group BEFREE This study shows that C-496T is both associated and linked with MD and that individuals possessing the fH C-496T C/C genotype are more likely to have increased serum fH protein levels, have reduced bactericidal activity against meningococci and be at an increased risk of contracting MD. 16938729 2006
Entrez Id: 3078
Gene Symbol: CFHR1
CFHR1
0.010 GeneticVariation group BEFREE The CFH-CFHR3-CFHR1 aHUS-risk haplotype seems to be the same as was previously associated with protection against meningococcal infections, suggesting that the genetic variability in this region is limited to a few extended haplotypes, each with opposite effects in various human diseases. 26163426 2015
Entrez Id: 10878
Gene Symbol: CFHR3
CFHR3
0.420 GeneticVariation group BEFREE These data may explain the association between genetic variation in both CFH and CFHR3 and susceptibility to meningococcal disease. 25534642 2014
Entrez Id: 10878
Gene Symbol: CFHR3
CFHR3
0.420 GeneticVariation group BEFREE The CFH-CFHR3-CFHR1 aHUS-risk haplotype seems to be the same as was previously associated with protection against meningococcal infections, suggesting that the genetic variability in this region is limited to a few extended haplotypes, each with opposite effects in various human diseases. 26163426 2015
Entrez Id: 10878
Gene Symbol: CFHR3
CFHR3
0.420 Biomarker group CTD_human Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
Entrez Id: 10878
Gene Symbol: CFHR3
CFHR3
0.420 GeneticVariation group GWASDB Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
Entrez Id: 10878
Gene Symbol: CFHR3
CFHR3
0.420 GeneticVariation group GWASCAT Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.020 GeneticVariation group BEFREE Three properdin deficiency phenotypes have been reported--complete deficiency (type I), incomplete deficiency (type II), and dysfunction of properdin protein (type III)--all associated with increased susceptibility to meningococcal disease. 9710744 1998
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.020 GeneticVariation group BEFREE Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). 10540191 1999
Entrez Id: 129684
Gene Symbol: CNTNAP5
CNTNAP5
0.100 GeneticVariation group GWASDB Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
Entrez Id: 1361
Gene Symbol: CPB2
CPB2
0.020 GeneticVariation group BEFREE TAFI 325 variants affect the outcome of meningococcal disease. 14717966 2004
Entrez Id: 1361
Gene Symbol: CPB2
CPB2
0.020 AlteredExpression group BEFREE TAFI levels were significantly decreased in patients with meningococcal disease at admission compared to the convalescence state. 18021301 2008
Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10
0.010 Biomarker group BEFREE Plasma CXCL10, but not CXCL11, was positively correlated (r = 0.67; P < 0.01) to LPS in patients (n = 24) with systemic meningococcal disease. 18362127 2008